Performance Characteristics of HIV-1 Culture and HIV-1 DNA and RNA Amplification Assays for Early Diagnosis of Perinatal HIV-1 Infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 5, 2003, Pages 512-519

  Lambert, John S ^a,b   Harris, D Robert ^c   Stiehm, E Richard ^d   Moye Jr , John ^e   Fowler, Mary Glenn ^f   Meyer III, William A ^g   Bethel, James ^c   Mofenson, Lynne M ^e  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c WESTAT   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

HIV 1 culture; HIV 1 DNA PCR; HIV 1 quantitative RNA; Infant diagnosis

Indexed keywords

ANTIRETROVIRUS AGENT; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS CULTURE; VIRUS DIAGNOSIS; VIRUS INFECTION;

EID: 0345490965     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200312150-00011     Document Type: Article

References (30)

1. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995;9: F7-F11.
2. Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses. 1995;11:353-361.
3. Stiehm ER, Lambert JS, Mofenson LM, et al. Efficacy of zidovudine and hyperimmune HIV immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group Protocol 185. J Infect Dis. 1999;179:567-575.
4. Hollinger FB, Bremer JW, Myers LE, et al. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol. 1992;30:1787-1794.
5. Hammer S, Crumpacker C, D'Aquila R, et al. Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J Clin Microbiol. 1993;31:2557-2564.
6. Fiscus SA, DeGruttola V, Gupta P, et al. Human immunodeficiency virus type I quantitative cell microculture as a measure of antiviral efficacy in multicenter clinical trial. J Infect Dis. 1995;171:305-311.
7. Hollinger FB, ed. Qualitative HIV-1 DNA Polymerase Chain Reaction (PCR) Assay. A CTG Virology Manual for Laboratories, Version 3.1. Bethesda, MD: Division of AIDS, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services; 1993.
8. Contoreggi CS, Jones SW, Lange WR, et al. Evaluation of HIV 1 infection status by HIV 1 PCR and culture methodologies in a small cohort of intravenous drug users. Res Virol. 1997;148:215-224.
9. Kellogg DE, Kwok S. Detection of human immunodeficiency virus. In: Innis MA, Gelfand DH, Sninsky JJ, et al, eds. PCR Protocols: A Guide to Methods and Applications. San Diego: Academic Press; 1990.
10. Kwok S, Mack DH, Mullis KB, et al. Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol. 1987;61:1690-1694.
11. Ou CY, Kwok S, Mitchell SW, et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science. 1988;239:295-297.
12. Ou CY, McDonald SH, Cabanas D, et al. Rapid and quantitative detection of enzymatic amplified DNA using chemiluminescent oligonucleotide probes. AIDS Res Hum Retroviruses. 1990;6:1323-1329.
13. Bugawan TL, Saiki RK, Levenson CH, et al. The use of nonradioactive oligonucleotide probes to analyze enzymatically amplified DNA for prenatal diagnosis and forensic HLA typing. Biotechnology. 1988;6:943-947.
14. Moye J, Mofenson L, Meyer W, et al. Comparability of rapidly processed and overnight shipped blood specimens for plasma HIV-1 RNA quantitation [abstract 316]. 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, February 1-5, 1998.
15. Yen-Lieberman B, Brambilla D, Jackson B, et al. Evaluation of a quality assurance program for quantification of human immunodeficiency virus type 1 RNA in plasma by AIDS Clinical Trials Group virology laboratories. J Clin Microbiol. 1996;34:2695-2701.
16. Gelber RV, Lindsey JC, MacWhinney S. Clinical trials to reduce the risk of maternal-infant transmission of HIV infection. In: Finkelstein DM, Shoenfetd DA, eds. AIDS Clinical Trials. New York: John Wiley & Sons; 1995.
17. Marubini E, Valsechhi MG. Analyzing survival data from clinical trials and observational studies. In: Finkelstein DM, Shoenfeld DA, eds. AIDS Clinical Trials. New York: John Wiley & Sons; 1995.
18. SAS Institute Inc. SAS/STA® User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute Inc.; 1990.
19. Burgard M, Mayaux M-J, Blanche S, et al. The use of viral culture and p24 antigen testing to diagnosis human immunodeficiency virus infection in neonates. N Engl J Med. 1992;327:1192-1197.
20. Krivine A, Yakudima A, Le May M, et al. A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr. 1990;116:372-376.
21. Manufacturer's package insert (2/99-RA). AMPLICOR HIV-1 MONITOR™ TEST, Standard/Ultrasensitive. Branchburg, NJ: Roche Diagnostic Systems, Inc.; 1999.
22. Delamare C, Burgard M, Mayaux M-J, et al. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. J Acquir Immune Defic Syndr. 1997;15:121-125.
23. Steketee RW, Abrams EJ, Thea DM, et al. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. J Infect Dis. 1997;175:707-711.
24. Cunningham CK, Charbonneau TT, Song K, et al. Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J. 1999;18:30-35.
25. Simonds RJ, Brown TM, Thea DM, et al. Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. AIDS. 1998;12:1545-1549.
26. Reisler RB, Thea DM, Pliner V, et al. Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: a comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction. J Acquir Immune Defic Syndr. 2001;26:93-102.
27. Nesheim S, Palumbo P, Sullivan K, et al. Quantitative RNA testing for diagnosis of HIV-infected infants. J AIDS. 2003;32:192-195.
28. Rouet F, Montcho C, Rouzioux C, et al. Early diagnosis of pediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay. AIDS. 2001;15:1849-1856.
29. Young NL, Shaffer N, Chaowanachan T, et al. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J AIDS. 2000;24:401-407.
30. Souza IE, Azevedo ML, Succi RC, et al. RNA viral load test for early diagnosis of vertical transmission of HIV-1 infection. J Acquir Immune Defic Syndr. 2000;23:358-360.